|
1 Indications And Usage Vigiv (Vaccinia Immune Globulin Intravenous, Human) Is Indicated For The Treatment And/or Modification Of The Following Conditions: • Eczema Vaccinatum • Progressive Vaccinia • Severe Generalized Vaccinia • Vaccinia Infections In Individuals Who Have Skin Conditions Such As Burns, Impetigo, Varicella-Zoster, Or Poison Ivy; Or In Individuals Who Have Eczematous Skin Lesions Because Of Either The Activity Or Extensiveness Of Such Lesions • Aberrant Infections Induced By Vaccinia Virus That Include Its Accidental Implantation In Eyes (Except In Cases Of Isolated Keratitis), Mouth, Or Other Areas Where Vaccinia Infection Would Constitute A Special Hazard. Vigiv Is Not Considered To Be Effective In The Treatment Of Postvaccinial Encephalitis. Vigiv Is An Immune Globulin (Human), 5% Liquid, Indicated For The Treatment Of Complications Due To Vaccinia Vaccination ( 1 ), Including: • Eczema Vaccinatum • Progressive Vaccinia • Severe Generalized Vaccinia • Vaccinia Infections In Individuals Who Have Skin Conditions • Aberrant Infections Induced By Vaccinia Virus (Except In Cases Of Isolated Keratitis) Vigiv Is Not Indicated For Postvaccinial Encephalitis ( 1 )
|